1. Home
  2. TECX vs LWAY Comparison

TECX vs LWAY Comparison

Compare TECX & LWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • LWAY
  • Stock Information
  • Founded
  • TECX 2019
  • LWAY 1986
  • Country
  • TECX United States
  • LWAY United States
  • Employees
  • TECX N/A
  • LWAY N/A
  • Industry
  • TECX
  • LWAY Packaged Foods
  • Sector
  • TECX
  • LWAY Consumer Staples
  • Exchange
  • TECX Nasdaq
  • LWAY Nasdaq
  • Market Cap
  • TECX 334.4M
  • LWAY 376.4M
  • IPO Year
  • TECX 2018
  • LWAY 1987
  • Fundamental
  • Price
  • TECX $22.88
  • LWAY $26.03
  • Analyst Decision
  • TECX Strong Buy
  • LWAY Hold
  • Analyst Count
  • TECX 5
  • LWAY 1
  • Target Price
  • TECX $79.00
  • LWAY N/A
  • AVG Volume (30 Days)
  • TECX 249.4K
  • LWAY 42.6K
  • Earning Date
  • TECX 08-13-2025
  • LWAY 08-12-2025
  • Dividend Yield
  • TECX N/A
  • LWAY N/A
  • EPS Growth
  • TECX N/A
  • LWAY N/A
  • EPS
  • TECX N/A
  • LWAY 0.67
  • Revenue
  • TECX N/A
  • LWAY $188,277,000.00
  • Revenue This Year
  • TECX N/A
  • LWAY $12.53
  • Revenue Next Year
  • TECX N/A
  • LWAY $12.08
  • P/E Ratio
  • TECX N/A
  • LWAY $38.59
  • Revenue Growth
  • TECX N/A
  • LWAY 12.84
  • 52 Week Low
  • TECX $13.70
  • LWAY $10.06
  • 52 Week High
  • TECX $61.07
  • LWAY $27.29
  • Technical
  • Relative Strength Index (RSI)
  • TECX 53.91
  • LWAY 63.20
  • Support Level
  • TECX $21.41
  • LWAY $24.40
  • Resistance Level
  • TECX $23.87
  • LWAY $27.00
  • Average True Range (ATR)
  • TECX 1.57
  • LWAY 0.74
  • MACD
  • TECX 0.08
  • LWAY 0.09
  • Stochastic Oscillator
  • TECX 54.84
  • LWAY 66.67

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About LWAY Lifeway Foods Inc.

Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir which is a cultured dairy product. Its product categories are Drinkable Kefir which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir and Other dairy. The company manufacture and market products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through direct sales force, brokers, and distributors.

Share on Social Networks: